Citiva Medical Mission
- To provide cutting-edge cannabinoid based products.
- To conduct research and develop partnerships with Universities, Hospitals and Institutions across the state to establish New York as the global epicenter for cannabinoid research.
- To establish programs to target specific illnesses and disease states, including childhood epilepsy, pediatric cancer, central nervous system disorders, chronic pain, post traumatic stress disorder, neuropathy, auto-immune dysfunction and multiple sclerosis.
- To develop a world market that accepts the concepts of Cannabinoid Replacement Therapy, creating a distribution and fulfillment network servicing medical cannabis consumers throughout the world.
A Revolution in BioTechnology
Citiva Medical is poised to not only benefit from this new BioTech revolution but to lead the fight to bring cannabinoid therapies to patients worldwide. Our team members are leaders and innovators in every aspect of this industry, starting with our founder, Josh Stanley.
Citiva Medical has a market advantage as a result of the demand created through Josh’s advocacy, our clinical evidence and our proprietary medical products.
Citiva Medical, in conjunction with our non-profit arm, Strains of Hope, is working to amass a large following of patients in areas such as pediatric epilepsy, chronic pain, AIDS/HIV, multiple sclerosis and cancer while educating the public about the benefits of medical marijuana.